Advertisement
Home 2017

Archives

Significant increases are seen in blood pressure

BP, Heart Rate, Arterial Stiffness Up With E-Cigarettes

0
Significant increases seen in first 30 minutes after smoking electronic-cigarette containing nicotine
Adjuvant therapy with nivolumab is associated with longer recurrence-free survival than therapy with ipilimumab among patients undergoing resection of stage IIIB

Adjuvant Nivolumab Tops Ipilimumab in Melanoma

0
Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma
Patients with chronic obstructive pulmonary disease with an eosinophilic phenotype may benefit from mepolizumab

Mepolizumab Beneficial in COPD With Eosinophilic Phenotype

0
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
For patients with resected stage III melanoma with BRAF V600E or V600K mutations

Dabrafenib, Trametinib Beneficial in Resected Melanoma

0
Rate of relapse-free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
For patients with moderate or severe obstructive sleep apnea

AAO-HNS: Improvement in OSA With Cranial Nerve Stimulation

0
Decrease in apnea-hypopnea index, and improvement in oxygen saturation, sleepiness, quality of life
Romosozumab treatment followed by alendronate is linked to reduced risk of fractures versus alendronate alone for postmenopausal women with osteoporosis

ASBMR: Romosozumab Reduces Fracture Rate in Osteoporosis

0
Reduced risk of new vertebral fractures, nonvertebral fractures for romosozumab and alendronate
For patients with locally advanced

Longer Progression-Free Survival for Durvalumab in NSCLC

0
Longer median progression-free survival from randomization, higher response rate with durvalumab
Repetitive transcranial magnetic stimulation is effective for auditory verbal hallucinations in patients with schizophrenia

Targeted rTMS Effective for Auditory Verbal Hallucinations

0
Higher percentage of responders among patients in active transcranial magnetic stimulation group
Outcomes of treatment with third-generation CAR T-cell therapy in CD19-positive B-cell malignancy are associated with patients' immune status

Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy

0
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Injection of inactivated modified vaccinia virus Ankara into tumors is effective and generates antitumor immunity

Inactivated Vaccinia Virus Shows Promise Against Advanced Cancer

0
Combined with immune checkpoint blockade therapy, iMVA generates synergistic antitumor effects